<\/p>\n \u30f4\u30a1\u30f3\u30c0\u30fc\u30d3\u30eb\u30c8\u5927\u5b66\u30e1\u30c7\u30a3\u30ab\u30eb\u30bb\u30f3\u30bf\u30fc\u306e\u533b\u5e2b\u4e3b\u5c0e\u6cbb\u9a13\u62c5\u5f53\u30d7\u30ed\u30b0\u30e9\u30e0\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bJessica Collins\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u4eca\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u53c2\u52a0\u3059\u308b\u88ab\u9a13\u8005\u306e\u8ca0\u62c5\u3092\u6e1b\u3089\u3057\u306a\u304c\u3089\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u8a66\u9a13\u5b9f\u65bd\u3092\u5bb9\u6613\u306b\u3059\u308b\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u304c\u5207\u306b\u6c42\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u8a66\u9a13\u306e\u4e00\u90e8\u3092\u30ea\u30e2\u30fc\u30c8\u3067\u884c\u3048\u308b\u3053\u3068\u306f\u3001\u88ab\u9a13\u8005\u4f53\u9a13\u306e\u5411\u4e0a\u3084\u8a66\u9a13\u5b9f\u65bd\u3092\u8fc5\u901f\u5316\u3059\u308b\u9375\u3068\u306a\u308a\u307e\u3059\u3002\u3053\u308c\u306f\u696d\u754c\u306b\u3068\u3063\u3066\u6975\u3081\u3066\u91cd\u8981\u306a\u8ee2\u63db\u3067\u3042\u308a\u3001³Ô¹Ï±¬ÁÏ\u304c\u3053\u306e\u91cd\u8981\u306a\u5206\u91ce\u306b\u3082\u305f\u3089\u3059\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u9ad8\u304f\u8a55\u4fa1\u3057\u307e\u3059\u3002\u300d<\/p>\n My³Ô¹Ï±¬ÁÏ\u306f\u3001\u5148\u9032\u7684\u306a\u30aa\u30fc\u30c7\u30a3\u30aa\uff0f\u30d3\u30c7\u30aa\u6a5f\u80fd\u306b\u3088\u3063\u3066\u88ab\u9a13\u8005\u3001\u533b\u5e2b\u3001\u304a\u3088\u3073\u6cbb\u9a13\u30b3\u30fc\u30c7\u30a3\u30cd\u30fc\u30bf\u30fc\u9593\u306e\u30ea\u30e2\u30fc\u30c8\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u5b9f\u73fe\u3057\u3001\u5bfe\u9762\u8a3a\u5bdf\u306e\u5fc5\u8981\u6027\u3092\u6e1b\u3089\u3057\u307e\u3059\u3002\u6cbb\u9a13\u8cac\u4efb\u533b\u5e2b\u306f\u88ab\u9a13\u8005\u30c7\u30fc\u30bf\u3092\u96fb\u5b50\u7684\u306b\u53ce\u96c6\u30fb\u8a18\u9332\u3067\u304d\u3001\u96fb\u5b50\u5a92\u4f53\u3067\u306e\u60c5\u5831\u5171\u6709\u3084\u88ab\u9a13\u8005\u306e\u540c\u610f\u53d6\u5f97\u304c\u5bb9\u6613\u306b\u306a\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u88ab\u9a13\u8005\u306b\u3068\u3063\u3066\u3082\u6cbb\u7642\u6210\u679c\u306e\u5831\u544a\u306b\u304a\u3051\u308b\u5229\u4fbf\u6027\u304c\u9ad8\u307e\u308b\u307b\u304b\u3001\u670d\u85ac\u3084\u6cbb\u7642\u8a08\u753b\u3078\u306e\u30a2\u30c9\u30d2\u30a2\u30e9\u30f3\u30b9\u306b\u3082\u5f79\u7acb\u3061\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ\u306eVault CDMS<\/a><\/strong>\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304a\u3088\u3073\u60a3\u8005\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u62c5\u5f53\u306e\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3067\u3042\u308bHenry Levy\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cCOVID-19\u306b\u3088\u308a\u3001\u3053\u308c\u307e\u3067\u4ee5\u4e0a\u306b\u81e8\u5e8a\u8a66\u9a13\u306e\u30d0\u30fc\u30c1\u30e3\u30eb\u5316\u3092\u9032\u3081\u3001\u5b89\u5168\u3067\u4fbf\u5229\u306a\u88ab\u9a13\u8005\u4f53\u9a13\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u304c\u6025\u52d9\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002My³Ô¹Ï±¬ÁÏ\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u3067\u5728\u5b85\u3067\u306e\u8a66\u9a13\u5b9f\u65bd\u304c\u53ef\u80fd\u306b\u306a\u308a\u3001\u3088\u308a\u60a3\u8005\u4e2d\u5fc3\u306e\u30da\u30fc\u30d1\u30fc\u30ec\u30b9\u306a\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u79fb\u884c\u3092\u4fc3\u9032\u3067\u304d\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u304c\u696d\u754c\u3068\u529b\u3092\u5408\u308f\u305b\u3066\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3001\u88ab\u9a13\u8005\u306e\u305f\u3081\u306b\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30bb\u30b9\u6539\u5584\u3092\u652f\u63f4\u3067\u304d\u308b\u3053\u3068\u3092\u5b09\u3057\u304f\u601d\u3044\u307e\u3059\u3002\u300d<\/p>\n My³Ô¹Ï±¬ÁÏ\u306f\u3001³Ô¹Ï±¬ÁÏ SiteVault\u3084³Ô¹Ï±¬ÁÏ Vault Clinical<\/a><\/strong>\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u3082\u3061\u308d\u3093\u3001\u30b5\u30fc\u30c9\u30d1\u30fc\u30c6\u30a3\u306e\u81e8\u5e8a\u8a66\u9a13\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3068\u3082\u67d4\u8edf\u306b\u7d44\u307f\u5408\u308f\u305b\u3066\u5229\u7528\u3067\u304d\u307e\u3059\u3002My³Ô¹Ï±¬ÁÏ\u306f2020\u5e7412\u6708\u306b\u63d0\u4f9b\u958b\u59cb\u3092\u4e88\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n My³Ô¹Ï±¬ÁÏ\u306f\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3001\u304a\u3088\u3073\u88ab\u9a13\u8005\u3092\u7d50\u3073\u4ed8\u3051\u3066\u81e8\u5e8a\u8a66\u9a13\u3092\u8fc5\u901f\u5316\u3059\u308b\u4e00\u9023\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3001³Ô¹Ï±¬ÁÏ Clinical Network\u306e\u4e00\u90e8\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ Vault Clinical Suite<\/a><\/strong>\u3068\u5408\u308f\u305b\u3066\u3001³Ô¹Ï±¬ÁÏ\u306f\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3001\u304a\u3088\u3073\u88ab\u9a13\u8005\u304c\u81e8\u5e8a\u8a66\u9a13\u4e2d\u306e\u60c5\u5831\u5171\u6709\u3084\u95b2\u89a7\u304c\u3067\u304d\u308b\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3059\u308b\u3001\u4e16\u754c\u521d\u304b\u3064\u4e16\u754c\u552f\u4e00\uff0a\u306e\u4f01\u696d\u3067\u3059\u3002<\/p>\n \uff0a\u5f53\u793e\u8abf\u3079<\/p>\n <\/p>\n \u3010<\/strong>³Ô¹Ï±¬ÁÏ Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011 My³Ô¹Ï±¬ÁÏ\u306f\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306b\u7121\u6599\u3067\u63d0\u4f9b\u3055\u308c\u3001³Ô¹Ï±¬ÁÏ SiteVault\u3068\u7d71\u5408<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-43621","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43621"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=43621"}],"version-history":[{"count":7,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43621\/revisions"}],"predecessor-version":[{"id":43636,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43621\/revisions\/43636"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=43621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=43621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=43621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"\"](\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2020\/06\/My³Ô¹Ï±¬ÁÏ-e1590999890653.jpg\")
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u3001850\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on F Form 10-K for the period ended January\u00a031, 2020. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"